In response to the Likert scale question “ If DAAs were available for treatment of HCV infection in children and adolescents in your practice/facility, how likely would you be to treat children in the following age groups ,” respondents showed a clear trend toward greater preference for treating older age groups, with the majority of the respondents stating they would be likely to treat children above 6 years of age ( Figure 2 ).
← all excerpts
Attitudes and perspectives of healthcare workers on treating chronic hepatitis C infection in children and adolescents.
1
—
—